The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 13, 2014

Primary Completion Date

March 2, 2017

Study Completion Date

September 18, 2017

Conditions

Chronic Ischemic Left Ventricular DysfunctionMyocardial Infarction

Interventions

BIOLOGICAL

Allogeneic hMSCs

Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection

Trial Locations (1)

ISCI / University of Miami, Miami

All Listed Sponsors

collaborator

The Emmes Company, LLC

INDUSTRY

lead

Joshua M Hare

OTHER

NCT02013674 - The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study) | Biotech Hunter | Biotech Hunter